ProCE Banner Activity

Targeting HER2, HER3, and TROP2 in Breast Cancer

Slideset Download
Download this slideset to review key data and expert perspectives on approved and emerging investigational HER2-, HER3-, and TROP2-targeted therapies for metastatic breast cancer.

Released: August 21, 2020

Expiration: August 20, 2021

No longer available for credit.

Share

Faculty

Mark D. Pegram

Mark D. Pegram, MD

Leonard M. Miller School of Medicine
University of Miami
Miami, Florida

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.

Program Director Disclosure

Program Director

Mark D. Pegram, MD

Leonard M. Miller School of Medicine
University of Miami
Miami, Florida